• Home
  • Disease & Drugs
  • Wellness
  • Health Tidings
  • Whitepapers
  • Newsletter
  • About
  • Home
  • Disease & Drugs
  • Wellness
  • Health Tidings
  • Whitepapers
  • Newsletter
  • About
  • Home
  • Disease & Drugs
  • Wellness
  • Health Tidings
  • Whitepapers
  • Newsletter
  • About

Home

Monthly Archives: May 2025

freepik__the-style-is-modern-and-it-is-a-detailed-illustrat__25089

Vitamin B12 Explained: Functions, Deficiency Signs, and Rich Sources Like Meat, Dairy, Eggs, and Fortified Foods

May 21, 2025
by official.ajinkya11@gmail.com Food

Medically Written and Reviewed By: Vikas Londhe, M.Pharm (Pharmacology)  Source: Freepik.com Vitamin B12 is a vital nutrient our body needs to stay healthy. It is a water-soluble vitamin; hence, it does not ...

Read More
0
IgAN

FDA Grants Accelerated Approval to Novartis’ Vanrafia (Atrasentan): First and Only Endothelin-1 Receptor Blocker for Proteinuria Reduction in IgA Nephropathy (IgAN)

May 19, 2025
by official.ajinkya11@gmail.com New Drug Approval

Written by: Priyanka Khamkar (M. Pharm., Pharmacology) and Sakshi Thakare (M. Pharm., Pharmacology) Source: Freepik.com The U.S. Food and Drug Administration (FDA) have granted accelerated approval to Novar ...

Read More
0
freepik__an-artistic-abstract-rendering-of-a-neuromuscular-__67190

FDA Approves Imaavy (nipocalimab-aahu), a Neonatal Fc Receptor (FcRn) Blocker, Offering New Hope for People Living with Generalized Myasthenia Gravis (gMG)

May 19, 2025
by official.ajinkya11@gmail.com New Drug Approval

Written by Priya Bhaware (M.Pharm. Pharmacology) Source: Freepik.com The Food and Drug Administration approved Imaavy (Nipocalimab-aahu) for the treatment of generalized myasthenia gravis (gMG) in adult and ...

Read More
0
portrait-man-suffering-from-schizophrenia_11zon

FDA Approval of Atzumi Marks a New Era in Migraine Treatment with SMART MucoAdhesive Delivery

May 19, 2025
by official.ajinkya11@gmail.com New Drug Approval

Written by:  Utkarsha Patil (M.Pharm., Pharmacology) and Shakuntala Kawhale (M.Pharm., Pharmacology) Source: Freepik.com The U.S. Food and Drug Administration (FDA) have approved Atzumi (dihydroergotamine m ...

Read More
0
close-up-examination-with-tongue-depressor_11zon

FDA Approves PD-1 Inhibitor Penpulimab-kcqx for Advanced Nasopharyngeal Carcinoma (NPC)

May 17, 2025
by official.ajinkya11@gmail.com New Drug Approval

Written By:  Samiksha Benke (M.Pharm., Pharmacology) and  Dr. Vinay Manocha (Pharm.D) Source: Freepik.com In the landmark development, U.S. Food and Drug Administration have approved innovative PD-1 monoclo ...

Read More
0
3d-medical-background-with-virus-cells-dna-strand_11zon

FDA Approves Zevaskyn (Prademagene Zamikeracel) for Recessive Dystrophic Epidermolysis Bullosa (RDEB): Gene Therapy Targets COL7A1 Gene and Boosts Type VII Collagen (C7)

May 17, 2025
by official.ajinkya11@gmail.com New Drug Approval

Written by:  Rikesh Dighore (M Pharm., Pharmacology) , and  Soniya Hajare (M Pharm.., Pharmacology) Source: Freepik.com For the treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB), the FDA has ap ...

Read More
0
freepik__a-microscopic-view-of-ovarian-cancer-cells-stained__53956

FDA Grants Accelerated Approval to Avmapki Fakzynja Co-Pack for KRAS-Mutated Low Grade Serous Ovarian Cancer (LGSOC) Targeting RAS/MAPK Pathway

May 16, 2025
by official.ajinkya11@gmail.com New Drug Approval

Written By: Shital Gaikwad (M.Pharm Pharmacology) and Shital Doifode (M.Pharm Pharmacology) In image ovarian cancer cells (Source: Freepik.com) In a significant progress in ovarian cancer treatment, the U.S ...

Read More
0
freepik__the-style-is-candid-image-photography-with-natural__20753

Japan First-in-the-World to approve Elevidys (Delandistrogene Moxeparvovec), one-of-the Costliest Gene Therapy Drug for Duchenne Muscular Dystrophy (DMD) in Children less than 4 years of age

May 15, 2025
by official.ajinkya11@gmail.com New Drug Approval

Written By: Pragati Ekamalli (B.Pharm)Reviewed By: Vikas Londhe M.Pharm (Pharmacology) Source: Freepik.com In a groundbreaking step forward for genetic medicine, Japan has become the first country in the wo ...

Read More
0
small-plastic-pieces-spoon_11zon

“Microplastics in Human Tissues: Insights from Nature Medicine and NEJM Studies”

May 14, 2025
by official.ajinkya11@gmail.com Research

Written By Lavanya Chavhan B.PharmReviewed and Fact Checked By Vikas Londhe M.Pharm (Pharmacology) Source: Freepik.com Microplastics and nanoplastics (MNPs) tiny particles resulting from the degradation of ...

Read More
0
young-couple-enjoying-yoga_11zon

Vyayama in Ayurveda: Principles, Benefits & Daily Routine for Physical Exercise

May 13, 2025
by official.ajinkya11@gmail.com Lifestyle

Medically Written and Reviewed By Ayurvedacharya Dr. Gaurav Pathare (BAMS) Source: Freepik.com In Ayurveda, the ultimate aim is to maintain the health of a healthy individual and to cure the disease of the ...

Read More
0
  • First
  • Previous
  • 1
  • 2
  • 3
  • 4
  • Next
  • Last

Recent Posts

  • After Second Liver Failure Death, Sarepta Therapeutics Halts Global Elevidys Dosing in Non-Ambulatory Duchenne Muscular Dystrophy Patients; Phase III ENVISION Trial Impacted
  • The Essence of Panchakarma: The Fivefold Path to Healing and Inner Balance
  • “UK’s Martha’s Rule: A Mother’s Fight That Sparked a National Reform and a Global Wake-Up Call on Patient Safety”
  • Stay Healthy This Monsoon: Ayurvedic Lifestyle Tips for Varsha Ritu
  • Moderna Launches mNEXSPIKE: New FDA-Approved COVID Vaccine for High-Risk Groups

Recent Comments

No comments to show.

Archives

  • June 2025
  • May 2025
  • April 2025
  • March 2025

About Us

  • About Us
  • Internship with us
  • Terms and Conditions

Categories

  • Clinical Trails
  • Disease & Drugs
  • Food
  • Health Tidings
  • Lifestyle
  • New Drug Approval
  • Research
  • Wellness
  • Women & Child Health

Pharmacally a brand of

MedCognize Communications (OPC) Pvt. Ltd.

Gat No. 405, Plot No. 17, Post-Nighoje, Near Faith Automation,

Opp. Anjali T Precision, Chakan Industrial Area, Pune 410501

Maharashtra, India

Contact No. - +91 9960598036

Email - contactus@pharmacally.com

  • About Us
  • Advisory Panel (Medical Experts)
  • About Founder
  • Source of Information

Follow Us -

Facebook Whatsapp Linkedin X-twitter
  • Internship with us
  • Advertise with us
  • Privacy Policy
  • Terms & Conditions

Subscribe to Newsletter -

SUBSCRIBE

Follow Us -

Facebook Whatsapp Linkedin X-twitter

Disclaimer: The content provided on the website is for information purposes only and is not intended as medical advice, diagnosis or treatment. Always seek doctors and other health provider’s advice in person regarding your any medical query or condition.

Copyright © 2025 Pharmacally | Designed by TEXPERT MENTOR

Shopping Basket